ATE441431T1 - Behandlung von nicht-septischen patienten mit verbrennungen zweiten grades mittels verabreichung von aktiviertem protein c - Google Patents

Behandlung von nicht-septischen patienten mit verbrennungen zweiten grades mittels verabreichung von aktiviertem protein c

Info

Publication number
ATE441431T1
ATE441431T1 AT07804504T AT07804504T ATE441431T1 AT E441431 T1 ATE441431 T1 AT E441431T1 AT 07804504 T AT07804504 T AT 07804504T AT 07804504 T AT07804504 T AT 07804504T AT E441431 T1 ATE441431 T1 AT E441431T1
Authority
AT
Austria
Prior art keywords
administration
burns
activated protein
treatment
degree burns
Prior art date
Application number
AT07804504T
Other languages
English (en)
Inventor
Myron Tsagarakis
Dimonsthenes Tsoutsos
Apostolos Papalois
Original Assignee
Myron Tsagarakis
Dimonsthenes Tsoutsos
Apostolos Papalois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myron Tsagarakis, Dimonsthenes Tsoutsos, Apostolos Papalois filed Critical Myron Tsagarakis
Application granted granted Critical
Publication of ATE441431T1 publication Critical patent/ATE441431T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07804504T 2006-09-01 2007-09-03 Behandlung von nicht-septischen patienten mit verbrennungen zweiten grades mittels verabreichung von aktiviertem protein c ATE441431T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20060100494A GR1005700B (el) 2006-09-01 2006-09-01 Τροπος αντιμετωπισης της 1ης φασης του εγκαυματοσσε μη σηπτικους ασθενεις με συνεχη ενδοφλεβια χορηγηση ενεργοποιημενης πρωτεινης-c για 48 ωρες με στοχο τη μειωση της τελικης εγκαυματικης βλαβης καιαυξηση της ταχυτητας επουλωσης κατα τα πρωτα επτα μετεγκαυματικα 24ωρα
PCT/GR2007/000043 WO2008026014A1 (en) 2006-09-01 2007-09-03 Management of non septic patients suffering from partial thickness burns during the first 48 postburn hours by administration of activated protein c

Publications (1)

Publication Number Publication Date
ATE441431T1 true ATE441431T1 (de) 2009-09-15

Family

ID=38683660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07804504T ATE441431T1 (de) 2006-09-01 2007-09-03 Behandlung von nicht-septischen patienten mit verbrennungen zweiten grades mittels verabreichung von aktiviertem protein c

Country Status (5)

Country Link
EP (1) EP1957098B1 (de)
AT (1) ATE441431T1 (de)
DE (1) DE602007002266D1 (de)
GR (1) GR1005700B (de)
WO (1) WO2008026014A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6273272B2 (ja) 2012-07-04 2018-01-31 ジージー バイオテック エルエルシー 炎症性皮膚障害の治療
WO2015157791A1 (en) 2014-04-16 2015-10-22 The University Of Sydney Treatment of abnormal cutaneous scarring

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401651A (en) * 1979-04-18 1983-08-30 Knutson Richard A Wound-healing compositions containing povidone-iodine
US4301145A (en) * 1980-07-28 1981-11-17 Cestari Joseph E Antiseptic skin cream
HUP0001237A3 (en) * 1997-10-20 2002-01-28 Lilly Co Eli Methods for treating vascular disorders
CA2450240A1 (en) * 2001-06-13 2002-12-19 The University Of Sydney Treatment and composition for wound healing

Also Published As

Publication number Publication date
EP1957098A1 (de) 2008-08-20
DE602007002266D1 (de) 2009-10-15
WO2008026014A1 (en) 2008-03-06
GR1005700B (el) 2007-10-22
EP1957098B1 (de) 2009-09-02

Similar Documents

Publication Publication Date Title
EA201070740A1 (ru) Способ лечения перелома кости антителами против склеростина
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
EA200971053A1 (ru) Способы лечения кожных язв
WO2010065077A3 (en) Antagonists of il-6 to prevent or treat thrombosis
MA32611B1 (fr) Procedes de traitement de la thalassemie
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
TW200724157A (en) A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
NO20091655L (no) Substituerte dihydropyrazoloner for behandling av kardiovaskulaere og hematologiske sykdommer
MA32872B1 (fr) Traitement du diabete chez des patients dont la regulation glycemique est insuffisante malgre une therapie par un medicament antidiabetique oralou non oral
ATE525084T1 (de) Verwendung von mindestens einem botulinum- neurotoxin zur behandlung von schmerzen infolge therapeutischer behandlungen für das aids-virus
WO2007070637A3 (en) Method of treating open wounds using hypochlorous acid
RU2013123796A (ru) Способ лечения болезни дюпюитрена
MA28005A1 (fr) Traitement preoperatoire de la douleur postoperatoire
Bongiovanni Effects of hypochlorous acid solutions on venous leg ulcers (VLU): experience with 1249 VLUs in 897 patients
Huang et al. Hyperbaric oxygen therapy for the management of chronic wounds: patient selection and perspectives
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
DE60330888D1 (de) Verwendung von drospirenon zur behandlung von hypertension
EA200702189A1 (ru) Способ лечения и профилактики диабета второго типа
ATE441431T1 (de) Behandlung von nicht-septischen patienten mit verbrennungen zweiten grades mittels verabreichung von aktiviertem protein c
RU2423118C1 (ru) Способ лечения трофических язв
ATE368473T1 (de) Behandlung von abweichungen der ersten metatarsophalangealen verbindung des fusses
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
WO2022047128A3 (en) Method for treating complement mediated disorders caused by betacoronaviruses
WO2006075932A3 (en) Remedy to accelerate healing of wound and burn

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties